首页> 外文OA文献 >PPD4-2-6: Feasibility of Adjuvant carboplatin/docetaxel (C/D) in patients (pts) resected stage I-IIIB non-small cell lung cancer (NSCLS): Preliminary report of a phase II trial

【2h】

PPD4-2-6: Feasibility of Adjuvant carboplatin/docetaxel (C/D) in patients (pts) resected stage I-IIIB non-small cell lung cancer (NSCLS): Preliminary report of a phase II trial

机译：PPD4-2-6：I-IIIB期非小细胞肺癌（NSCLS）切除患者（pts）接受卡铂/多西他赛（C / D）的可行性：II期试验的初步报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Stinchcombe Thomas E.; Socinski Mark A.; Harper Harry D.; Hensing Thomas A.; Moore Dominic T.; Crane Jeffrey M.; Atkins James N.; Willard Ellen M.; Tynan Maureen T.; Gulino Sara E.;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503 [J] . Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2020,第期

机译：随机期II试验与多西紫杉醇加发球菌的佐剂化疗试验与PACLitaxel Plus Carboplatin完全切除的非小细胞肺癌患者：Torg 0503
2. Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial [J] . Noriyasu Usami, Kohei Yokoi, Yoshinori Hasegawa, International Journal of Clinical Oncology . 2010,第6期

机译：卡铂和吉西他滨辅助化疗在完全切除的非小细胞肺癌患者中的II期研究：日本中部肺研究小组CJLSG 0503试验的报告
3. Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial. [J] . Usami N, Yokoi K, Hasegawa Y, International journal of clinical oncology . 2010,第6期

机译：CARBOPLATIN和GEMCITABINE作为辅助化疗的II期研究，患者完全切除的非小细胞肺癌：中部肺部研究组的报告，CJLSG 0503试验。
4. FDG uptake as a biological prognostic factor for recurrence in patients with surgically resected stage Ⅰ non-small cell lung cancer [C] . The First China-Japan-Korea conference of nuclear medicine . 2002

机译：手术切除的Ⅰ期非小细胞肺癌患者FDG摄取是复发的生物学预后因素
5. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
6. A phase 2 study of adjuvant carboplatin plus S-1 followed by maintenance S-1 therapy for patients with completely resected stage II/IIIA non-small cell lung cancer—Japanese Northern East Area Thoracic Surgery Study Group JNETS1302 study [O] . Takeo Hasegawa, Hiroyuki Suzuki, Jiro Abe, 2020

机译：佐剂卡铂加S-1的2阶段研究然后进行维持患者的疗效适用于完全切除阶段II / IIIA非小细胞肺癌 - 日北方地区胸外科研究组JNETS1302研究
7. P2-221: Adjuvant docetaxel plus carboplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer: preliminary results of the Chinese Society of Lung Cancer randomised controlled trial (CSLC201) [O] . Wu Yi-Long, Yang Xue-Ning, Chen Gang, 2007

机译：P2-221：多西他赛联合卡铂的辅助治疗与完全切除的IB-IIIA期非小细胞肺癌患者的观察：中国肺癌学会随机对照试验（CSLC201）的初步结果

PPD4-2-6: Feasibility of Adjuvant carboplatin/docetaxel (C/D) in patients (pts) resected stage I-IIIB non-small cell lung cancer (NSCLS): Preliminary report of a phase II trial

著录项

引文网络

相似文献

相关主题

期刊订阅